Vivistim

Vivistim: Advancing Stroke Rehabilitation Through NeuromodulationVivistim is a groundbreaking neuromodulation system developed by MicroTransponder, a medical technology company based in Austin, Texas. The Vivistim Paired Vagus Nerve Stimulation (VNS) System is FDA-approved and designed to restore upper limb function in adults who have experienced a chronic ischemic stroke. It represents a major advancement in stroke rehabilitation by combining vagus nerve stimulation with task-specific physical and occupational therapy to enhance the brains ability to rewire itselfa process known as neuroplasticity.How Vivistim WorksVivistim involves a small, implantable pulse generator placed under the skin in the chest, connected to a lead that stimulates the vagus nerve. During therapy, a clinician wirelessly triggers the device as patients perform specific motor tasks. This pairing of movement and nerve stimulation reinforces brain pathways, leading to significantly improved motor function. After the clinical therapy phase, patients can continue therapy at home by using a handheld magnet to activate the system during daily activities.Clinical BenefitsClinical studies have shown that stroke survivors using Vivistim experience two to three times greater improvements in upper limb mobility compared to conventional therapy alone. These gains are not only statistically significant but also translate into real-life benefits such as increased independence and improved quality of life. The system has also received the FDA~s Breakthrough Device designation due to its transformative potential.Who Its ForVivistim is designed for adults who are at least six months post-ischemic stroke and continue to experience moderate to severe weakness in their arm or hand. Ideal candidates have reached a recovery plateau with traditional therapy but still retain some movement in the wrist, thumb, and at least two fingers. The treatment involves a collaborative care model including neurosurgeons, neurologists or physiatrists, and specially trained therapists.Adoption and ExpansionVivistim is already in use at leading healthcare institutions and is supported by a growing body of clinical research and real-world patient outcomes. Ongoing studies are exploring its application for other stroke-related impairments, such as lower limb mobility and speech. The technology builds on decades of research and clinical use of vagus nerve stimulation for conditions like epilepsy and depression, demonstrating its safety and effectiveness.About MicroTransponderMicroTransponder is committed to developing innovative neuromodulation technologies that improve the lives of people with neurological disorders. With Vivistim, the company is redefining what is possible in stroke recovery by offering a proven, science-backed system that helps patients regain movement, confidence, and independence.

Vivistim: Advancing Stroke Rehabilitation Through NeuromodulationVivistim is a groundbreaking neuromodulation system developed by MicroTransponder, a medical technology company based in Austin, Texas. The Vivistim Paired Vagus Nerve Stimulation (VNS) System is FDA-approved and designed to restore upper limb function in adults who have experienced a chronic ischemic stroke. It represents a major advancement in stroke rehabilitation by combining vagus nerve stimulation with task-specific physical and occupational therapy to enhance the brains ability to rewire itselfa process known as neuroplasticity.How Vivistim WorksVivistim involves a small, implantable pulse generator placed under the skin in the chest, connected to a lead that stimulates the vagus nerve. During therapy, a clinician wirelessly triggers the device as patients perform specific motor tasks. This pairing of movement and nerve stimulation reinforces brain pathways, leading to significantly improved motor function. After the clinical therapy phase, patients can continue therapy at home by using a handheld magnet to activate the system during daily activities.Clinical BenefitsClinical studies have shown that stroke survivors using Vivistim experience two to three times greater improvements in upper limb mobility compared to conventional therapy alone. These gains are not only statistically significant but also translate into real-life benefits such as increased independence and improved quality of life. The system has also received the FDA~s Breakthrough Device designation due to its transformative potential.Who Its ForVivistim is designed for adults who are at least six months post-ischemic stroke and continue to experience moderate to severe weakness in their arm or hand. Ideal candidates have reached a recovery plateau with traditional therapy but still retain some movement in the wrist, thumb, and at least two fingers. The treatment involves a collaborative care model including neurosurgeons, neurologists or physiatrists, and specially trained therapists.Adoption and ExpansionVivistim is already in use at leading healthcare institutions and is supported by a growing body of clinical research and real-world patient outcomes. Ongoing studies are exploring its application for other stroke-related impairments, such as lower limb mobility and speech. The technology builds on decades of research and clinical use of vagus nerve stimulation for conditions like epilepsy and depression, demonstrating its safety and effectiveness.About MicroTransponderMicroTransponder is committed to developing innovative neuromodulation technologies that improve the lives of people with neurological disorders. With Vivistim, the company is redefining what is possible in stroke recovery by offering a proven, science-backed system that helps patients regain movement, confidence, and independence.

Vivistim: Advancing Stroke Rehabilitation Through NeuromodulationVivistim is a groundbreaking neuromodulation system developed by MicroTransponder, a medical technology company based in Austin, Texas. The Vivistim Paired Vagus Nerve Stimulation (VNS) System is FDA-approved and designed to restore upper limb function in adults who have experienced a chronic ischemic stroke. It represents a major advancement in stroke rehabilitation by combining vagus nerve stimulation with task-specific physical and occupational therapy to enhance the brains ability to rewire itselfa process known as neuroplasticity.How Vivistim WorksVivistim involves a small, implantable pulse generator placed under the skin in the chest, connected to a lead that stimulates the vagus nerve. During therapy, a clinician wirelessly triggers the device as patients perform specific motor tasks. This pairing of movement and nerve stimulation reinforces brain pathways, leading to significantly improved motor function. After the clinical therapy phase, patients can continue therapy at home by using a handheld magnet to activate the system during daily activities.Clinical BenefitsClinical studies have shown that stroke survivors using Vivistim experience two to three times greater improvements in upper limb mobility compared to conventional therapy alone. These gains are not only statistically significant but also translate into real-life benefits such as increased independence and improved quality of life. The system has also received the FDA~s Breakthrough Device designation due to its transformative potential.Who Its ForVivistim is designed for adults who are at least six months post-ischemic stroke and continue to experience moderate to severe weakness in their arm or hand. Ideal candidates have reached a recovery plateau with traditional therapy but still retain some movement in the wrist, thumb, and at least two fingers. The treatment involves a collaborative care model including neurosurgeons, neurologists or physiatrists, and specially trained therapists.Adoption and ExpansionVivistim is already in use at leading healthcare institutions and is supported by a growing body of clinical research and real-world patient outcomes. Ongoing studies are exploring its application for other stroke-related impairments, such as lower limb mobility and speech. The technology builds on decades of research and clinical use of vagus nerve stimulation for conditions like epilepsy and depression, demonstrating its safety and effectiveness.About MicroTransponderMicroTransponder is committed to developing innovative neuromodulation technologies that improve the lives of people with neurological disorders. With Vivistim, the company is redefining what is possible in stroke recovery by offering a proven, science-backed system that helps patients regain movement, confidence, and independence.

Vivistim: Advancing Stroke Rehabilitation Through NeuromodulationVivistim is a groundbreaking neuromodulation system developed by MicroTransponder, a medical technology company based in Austin, Texas. The Vivistim Paired Vagus Nerve Stimulation (VNS) System is FDA-approved and designed to restore upper limb function in adults who have experienced a chronic ischemic stroke. It represents a major advancement in stroke rehabilitation by combining vagus nerve stimulation with task-specific physical and occupational therapy to enhance the brains ability to rewire itselfa process known as neuroplasticity.How Vivistim WorksVivistim involves a small, implantable pulse generator placed under the skin in the chest, connected to a lead that stimulates the vagus nerve. During therapy, a clinician wirelessly triggers the device as patients perform specific motor tasks. This pairing of movement and nerve stimulation reinforces brain pathways, leading to significantly improved motor function. After the clinical therapy phase, patients can continue therapy at home by using a handheld magnet to activate the system during daily activities.Clinical BenefitsClinical studies have shown that stroke survivors using Vivistim experience two to three times greater improvements in upper limb mobility compared to conventional therapy alone. These gains are not only statistically significant but also translate into real-life benefits such as increased independence and improved quality of life. The system has also received the FDA~s Breakthrough Device designation due to its transformative potential.Who Its ForVivistim is designed for adults who are at least six months post-ischemic stroke and continue to experience moderate to severe weakness in their arm or hand. Ideal candidates have reached a recovery plateau with traditional therapy but still retain some movement in the wrist, thumb, and at least two fingers. The treatment involves a collaborative care model including neurosurgeons, neurologists or physiatrists, and specially trained therapists.Adoption and ExpansionVivistim is already in use at leading healthcare institutions and is supported by a growing body of clinical research and real-world patient outcomes. Ongoing studies are exploring its application for other stroke-related impairments, such as lower limb mobility and speech. The technology builds on decades of research and clinical use of vagus nerve stimulation for conditions like epilepsy and depression, demonstrating its safety and effectiveness.About MicroTransponderMicroTransponder is committed to developing innovative neuromodulation technologies that improve the lives of people with neurological disorders. With Vivistim, the company is redefining what is possible in stroke recovery by offering a proven, science-backed system that helps patients regain movement, confidence, and independence.